Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Wereldwijd onderzoek naar genetica teruggekeerde hersentumoren
dec 2019 | Neuro-oncologie